DOI:
10.1055/s-00023610
Drug Research
Issue 02 ·
Volume 66 ·
February 2016
DOI: 10.1055/s-006-30995
Opinion Paper
Original Article
74
Kasahara, N.;
Fukase, H.;
Ohba, Y.;
Saito, T.;
Miyata, K.;
Iida, S.;
Takano, Y.;
Ikeda, S.;
Harigai, M.;
Terao, K.:
A Pharmacokinetic/Pharmacodynamic Drug–Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs
107
Jain, M. R.;
Joharapurkar, A. A.;
Pandya, V.;
Patel, V.;
Joshi, J.;
Kshirsagar, S.;
Patel, K.;
Patel, P. R.;
Desai, R. C.:
Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia